 |
|
|
|
|
PepTech Taps Dr. Bing Chen to Lead Business Development Expansion
CAMBRIDGE, Mass., Oct. 27, 2023 /PRNewswire/ -- PepTech Corp, a leading pharmaceutical services company, today announced the appointment of Dr. Bing Chen as Vice President of Business Development, effective October 27, 2023.
In this role, Dr. Chen will be responsible for expanding PepTech's client relationships and driving new business opportunities. He will oversee marketing, sales, and alliance functions across the company.
Dr. Chen brings over 15 years of pharmaceutical industry experience to PepTech. He joins the company from HaoYue China Healthcare Fund, where he served as Investment Vice President focused on biopharmaceutical investments. Previously, he held positions at PepTech (Shanghai) Pharmaceutical R&D.
"We are delighted to welcome Dr. Chen to the PepTech team," said James Ma, President of PepTech. "His expertise in pharmaceutical R&D and business development will be invaluable as we continue growing our services and capabilities. Dr. Chen has a proven track record of building strong client partnerships and delivering innovative solutions."
Dr. Chen holds a Ph.D. in Bioengineering from East China University of Science and Technology, a joint MBA from CEIBS in Shanghai, and the Kellogg School of Management at Northwestern University. He has co-authored several publications and patents related to drug discovery.
About PepTech
PepTech Corp provides contract development and manufacturing services to the global pharmaceutical industry. With locations across the U.S. and China, PepTech offers end-to-end solutions for active pharmaceutical ingredient development, clinical to commercial manufacturing, and pharmaceutical services.
|
|
|
|
|
|